What is Aqsa Khan's NPI number?

Aqsa Khan's National Provider Identifier (NPI) is 1164661765, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Aqsa Khan's specialty?

Aqsa Khan is listed in the NPPES registry with a primary specialty of Urology Physician (Allopathic & Osteopathic Physicians).

Where is Aqsa Khan located?

Aqsa Khan's practice location on file with NPPES is 13400 E Shea Blvd, Scottsdale, AZ 85259-5452.

What is Aqsa Khan's phone number?

The practice phone number listed in the NPPES registry for Aqsa Khan is (480) 301-8000.

Does Aqsa Khan accept Medicare?

Aqsa Khan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Aqsa Khan's NPI active?

Yes — Aqsa Khan's NPI (1164661765) is active in the NPPES registry as of the last update on 2020-09-08.

IndividualActiveAccepts Medicare

Aqsa Khan, MD

NPI 1164661765 · Urology Physician · Scottsdale, AZ

Aqsa Khan, MD is a Urology Physician provider in Scottsdale, AZ (NPI 1164661765).

Provider details

NPI number: 1164661765
Entity type: Individual
Primary specialty: Urology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: CA108254 (CA)

Practice location

13400 E Shea Blvd

Scottsdale, AZ 85259-5452

Phone: (480) 301-8000

Street-level locationGet directions

More AZ providers

Mailing address

13400 E Shea Blvd

Scottsdale, AZ 85259-5452

Specialties & taxonomies

Urology PhysicianPrimary208800000XLicense 50838 (AZ)
Allopathic & Osteopathic Physicians
Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician2088F0040XLicense CA108254 (CA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(79/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
17 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,684 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Electronic Assessment of Bladder Emptying51741	466	$11
Ultrasound Measurement of Bladder Capacity After Voiding51798	458	$11
Diagnostic Exam of Bladder and Urethra Using an Endoscope52000	166	$214
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	165	$121
Non-Needle Measurement and Recording of Electrical Activity of Muscles at Bladder and Bowel Openings51784	159	$31
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Vibegronbrand: Gemtesa	57	17
Estradiol	47	32
Mirabegronbrand: Myrbetriq	18	—
Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro	15	15
Methenamine Hippurate	14	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$172 across 2 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2009-02-05
Last updated: 2020-09-08
Certified: 2020-09-08

Frequently asked questions

What is Aqsa Khan's NPI number?: Aqsa Khan's National Provider Identifier (NPI) is 1164661765, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Aqsa Khan's specialty?: Aqsa Khan is listed in the NPPES registry with a primary specialty of Urology Physician (Allopathic & Osteopathic Physicians).
Where is Aqsa Khan located?: Aqsa Khan's practice location on file with NPPES is 13400 E Shea Blvd, Scottsdale, AZ 85259-5452.
What is Aqsa Khan's phone number?: The practice phone number listed in the NPPES registry for Aqsa Khan is (480) 301-8000.
Does Aqsa Khan accept Medicare?: Aqsa Khan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Aqsa Khan's NPI active?: Yes — Aqsa Khan's NPI (1164661765) is active in the NPPES registry as of the last update on 2020-09-08.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Electronic Assessment of Bladder Emptying51741	466	$11
Ultrasound Measurement of Bladder Capacity After Voiding51798	458	$11
Diagnostic Exam of Bladder and Urethra Using an Endoscope52000	166	$214
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	165	$121
Non-Needle Measurement and Recording of Electrical Activity of Muscles at Bladder and Bowel Openings51784	159	$31
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Vibegronbrand: Gemtesa	57	17
Estradiol	47	32
Mirabegronbrand: Myrbetriq	18	—
Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro	15	15
Methenamine Hippurate	14	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$172 across 2 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments